Table 7.
Results—liver recipients
| G1 (n=6) | G2 (n=6) | |
|---|---|---|
| PNF | 3 (50%) | 0 (0%) |
| Peak bilirubin (mg/dl) (1st week)a | 4.2±0.4 | 8.7±8.3 mg/dl |
| Peak SGOT (IU/L) (1st week)a | 1135±955 | 693 ±327 |
| Retransplant rate | 5/6 (83.3%) | 2/6 (33.3%) |
| Indication for retransplantation | PNF = 2 Technical = 2 CMV hepatitis = 1 |
Hepatitis = 1 Arterial vasculitis = 1 |
| Deaths | 2/6 | 3/6 |
| Causes of death | Stroke = 1 CMV = 1 |
MI =* 2 Sepsis = 1 |
| Mean follow-up (months) | 32±21 (range 7–58) | 17.5±8.5 (range 6–23) |
| 1-Year patient survival | 67% | 50% |
| 1-Year graft survival | 17% | 50% |
a
Functioning livers.